A prospective, multicenter, randomized, placebo-controlled trial of physiologic testosterone supplementation for HIV-positive men with mildly to moderately reduced serum testosterone levels and abdominal obesity

Trial Profile

A prospective, multicenter, randomized, placebo-controlled trial of physiologic testosterone supplementation for HIV-positive men with mildly to moderately reduced serum testosterone levels and abdominal obesity

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2012

At a glance

  • Drugs Testosterone (Primary)
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 03 Apr 2012 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
    • 12 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top